remimazolam may have patient safety implications in patients with liver disease - part 3 of 3
Published 8 months ago • 90 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
0:54
remimazolam: patient safety considerations - part 1 of 3
-
1:06
remimazolam is fast-acting with a short half-life - part 2 of 3
-
15:28
#176 keeping patients safe with remimazolam administration, part 2
-
17:59
#175 remimazolam, a new medication on the anesthesia block, part 1
-
16:11
#76 the past, present, and future of lma use
-
2:30
pioneering patient safety
-
1:25
safety and efficacy of linvoseltamab for patients with r/r multiple myeloma
-
0:24
the importance of medrec – a pharmacist’s perspective
-
0:15
medication reminders and home care
-
2:18
dr. muhamid asif: always listening to his patients
-
2:32
the safety and efficacy of isatuximab for r/r myeloma: insights from icaria-mm, ikema & candor
-
58:08
stay tuned for patient safety: alarms and data in the icu
-
1:07
what to include in your medication list
-
4:52
medpace clinical pharmacology - volunteers
-
3:31
metavision (or): improved patient care
-
0:08
artificial intelligence in medicine | healthcare hot topics
-
1:03
the medicines adaptive pathways to patients (mapps) and its importance in oncology
-
16:38
maximizing medication therapy management technology to extend the reach of the pharmacist